The coronavirus disease 2019 (COVID-19) is now the third-leading cause of death in the United States; the FDA issued an alert for a COVID-19 test; promoting pediatric eye care as schools go virtual.
According to The Hill, coronavirus disease 2019 (COVID-19) is now the third-leading cause of death in the United States, with approximately 170,434 attributed deaths. Behind only heart disease and cancer, COVID-19 is now a greater cause of death than lung disease, diabetes, and Alzheimer disease. Extending to more than 5.4 million cases nationwide, and an average of more than 1000 deaths per day, the rate of death due to COVID-19 has been indicated as 8 times more likely in the United States than in Europe. Furthermore, potential cases may be understated as testing has fallen by an average of 68,000 per day, with 15 states conducting fewer tests than last week.
Yesterday, the FDA issued an alert to doctors and laboratory technicians using Thermo Fisher’s TaqPath genetic test as it has been linked with potential accuracy issues that may lead to false results for patients. Reported by The Associated Press, regulators said the cause of the inaccuracies were the laboratory equipment and the software used to run the test, which have since been updated to ensure accurate results. The FDA did not provide further details on how many test results have been affected by the issue.
As school districts nationwide employ fully remote or hybrid learning models amid the COVID-19 pandemic, children may be at greater risk of eye strain, fatigue, and headaches due to increased screen-based instruction. The New York Times reported that myopia in children, also known as nearsightedness, has been on the rise potentially due to screen usage. To combat these risks, a pediatric ophthalmologist recommends keeping devices about 2 feet away and at eye level. Beyond regular breaks in screen usage, a position suggested to be an acceptable working distance entails children placing an elbow on the table, resting their head on that hand, and ultimately lifting their elbow to touch the screen.
Dr Robert Sidbury: Best Practices for Managing Atopic Dermatitis in InfantsJune 6th 2023
Robert Sidbury, MD, MPH, professor of pediatrics at Seattle Children's Hospital, discusses best practices that physicians and parents of infants with atopic dermatitis (AD) can do to help manage flare- ups, as well as barriers to care, which he presented at the Revolutionizing Atopic Dermatitis conference.
Navigating Medicare's Part D Subsidy Program to Achieve Value-Based CareMay 26th 2023
On this episode of Managed Care Cast, we speak with the lead researcher from a study published in the May 2023 issue of The American Journal of Managed Care® about the impact of low-income subsidies on the uptake and equitable use of expensive orally administered antimyeloma therapy.
Health Equity Conversations: Managing Underserved Communities and Value-Based PaymentMay 23rd 2023
On this episode of Managed Care Cast, we feature several leaders in diversity, equity, and inclusion advancing health equity in their respective organization’s policy and practice initiatives.
Building Research Capacity in Primary Care Practices That Serve Predominantly Racial and Ethnic Minority PopulationsJune 6th 2023
The successful collaboration between a primary care–based network of practices and academic researchers demonstrates feasibility and the need for more funding for primary care research.
2 Clarke Drive
Cranbury, NJ 08512